EKOS Corp. studying new use for its ultrasound technology

EKOS Corporation, a Bothell-based medical device company, is hearing from doctors that they are using the company’s ultrasound technology for dissolving blood clots in a new target – the lungs. As a result of this anecdotal information, EKOS has announced plans to conduct a clinical study on treatment of pulmonary embolism with the company’s product.

Read more at Xconomy

Read more in an EKOS press release

EKOS Corporation is a WTC client

This entry was posted in Bothell, Company_and_Client_News, EKOS, Life_Sciences. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s